JUL 1, 2026 · REGULATORY APPROVAL
FDA approval: Brimonidine Tartrate AND Timolol Maleate
U.S. Food and Drug Administration
FDA approval of a fixed-dose combination ophthalmic drop; this is a regulatory action, not a clinical trial, and does not report efficacy or comparative outcomes.
Reported
Brimonidine tartrate concentration0.2%
Timolol maleate concentration (eq…0.5%
Approval date2026-07-01